SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-21-000652
Filing Date
2021-09-21
Accepted
2021-09-21 16:51:43
Documents
2
Group Members
POINT72 CAPITAL ADVISORS, INC.POINT72 HONG KONG LTDSTEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G p13ga.htm SC 13G 55647
2 JOINT FILING AGREEMENT p13gb.htm EX-96.1 2769
  Complete submission text file 0000899140-21-000652.txt   60099
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89290 | Film No.: 211267026
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G